In the first six months of 2024, the Inflation Reduction Act has saved 1.5 million Medicare Part D enrollees nearly $1 billion in out-of-pocket prescription drug costs, HHS said Oct. 22.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
